[Bug 459631] Review Request: insight - GDB debugger GUI

[bugzilla at redhat.com]

Please do not reply directly to this email. All additional
comments should be made in the comments box of this bug.


https://bugzilla.redhat.com/show_bug.cgi?id=459631


Dominik 'Rathann' Mierzejewski <rpm at greysector.net> changed:

           What    |Removed                     |Added
----------------------------------------------------------------------------
             Blocks|                            |182235




--- Comment #3 from Dominik 'Rathann' Mierzejewski <rpm at greysector.net>  2008-08-20 17:10:09 EDT ---
One more link:
http://accelrys.com/products/additional-products.html (Scroll down to "Rational
and Structure-Based Drug Design")
While Insight II is being phased out in favour of Discovery Studio, it is still
widely used (for example at my workplace, which is why this review request
caught my eye).

(In reply to comment #2)
> Good links... I did not know this chemical software !
> However this is the cygwin's program name for years (it used to be called
> "gdbtk"), and is now owned (under this name) by... RedHat :) It is part of the
> cygwin's "gdb" package.

Yes, I know and I'm surprised this hasn't come up even on their own mailing
lists.

> Debian has kept the name: http://packages.debian.org/lenny/insight
> 
> I'm not against renaming it, but how ?

I'm not saying it has to be renamed. I'm just pointing to a potential issue. :)

> gdbtk ? gdb-insight ? rhinsight ? ... ?
> And do we rename the /usr/bin/insight command too ?
> Wouldn't it confuse the user ?
> Is it a potential RH legal problem ?

That's what I'd like to know. I've blocked FE-Legal here and mentioned this to
spot.

-- 
Configure bugmail: https://bugzilla.redhat.com/userprefs.cgi?tab=email
------- You are receiving this mail because: -------
You are on the CC list for the bug.